Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2013.09.14
2013年第一次暂时股东大会的执法意见书
2013.09.14
2013年第一次暂时股东大会决议通告
2013.09.14
关于公司高级治理职员告退的通告
2013.08.29
第二届监事会第二十四次聚会决议通告
2013.08.29
2013年半度召募资金存放与使用情形的专项报告
2013.08.29
关于调解2013年度部分一样平常关联生意预计的通告
2013.08.29
关于召开2013年第一次暂时股东大会的通知通告
2013.08.29
关于向银行申请专项授信额度的通告
2013.08.29
关于变换会计师事务所的通告
2013.08.29
关于变换部分召募资金存放专项账户并签署召募资金三方羁系协议的通告
第一页
上一页
117
118
119
120
121
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】